Education
About Us
Working with TipRanks
Follow Us
Actinogen Medical Limited (AU:ACW)
:ACW
ACW Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.02 - AU$0.05
Previous CloseN/A
Volume244.11K
Average Volume (3M)2.20M
Market Cap
AU$101.60M
Enterprise ValueAU$59.83M
Total Cash (Recent Filing)AU$22.87M
Total Debt (Recent Filing)AU$289.64K
Price to Earnings (P/E)―
Beta0.56
Next Earnings
Feb 19, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding3,175,147,200
10 Day Avg. Volume4,243,934
30 Day Avg. Volume2,196,617
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
Actinogen Medical News
ACW FAQ
What was Actinogen Medical Limited’s price range in the past 12 months?
Actinogen Medical Limited lowest share price was AU$0.02 and its highest was AU$0.05 in the past 12 months.
What is Actinogen Medical Limited’s market cap?
Actinogen Medical Limited’s market cap is AU$101.60M.
When is Actinogen Medical Limited’s upcoming earnings report date?
Actinogen Medical Limited’s upcoming earnings report date is Feb 19, 2026 which is in 174 days.
How were Actinogen Medical Limited’s earnings last quarter?
Actinogen Medical Limited released its earnings results on Aug 25, 2025. The company reported -AU$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.002.
Is Actinogen Medical Limited overvalued?
According to Wall Street analysts Actinogen Medical Limited’s price is currently Overvalued.
Does Actinogen Medical Limited pay dividends?
Actinogen Medical Limited does not currently pay dividends.
What is Actinogen Medical Limited’s EPS estimate?
Actinogen Medical Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Actinogen Medical Limited have?
Actinogen Medical Limited has 3,175,147,200 shares outstanding.
What happened to Actinogen Medical Limited’s price movement after its last earnings report?
Actinogen Medical Limited reported an EPS of -AU$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -6.667%.
Which hedge fund is a major shareholder of Actinogen Medical Limited?
Currently, no hedge funds are holding shares in AU:ACW
Actinogen Medical Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
― (―)
― (―)
Blogger Sentiment
Bullish
AU:ACW Sentiment 70%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
78.57%
12-Months-Change
Fundamentals
Return on Equity
-75.99%
Trailing 12-Months
Asset Growth
12.72%
Trailing 12-Months
Company Description
Actinogen Medical Limited
Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It is developing Xanamem, an inhibitor of the 11ß-HSD1 enzyme, which is in Phase 2 clinical trials that achieves target engagement in the central nervous system, Alzheimer's disease, depression with cognitive impairment, and anxiety, sleep, and behavioral problems in fragile X syndrome. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited was incorporated in 1999 and is based in Sydney, Australia.
Technical Analysis
Alterity Therapeutics
―
Prescient Therapeutics Limited
―
Radiopharm Theranostics Limited
―
EZZ Life Science Holdings Ltd.
―
Arovella Therapeutics Limited
―
Ownership Overview
6.71% Insiders
―
Mutual Funds
― Other Institutional Investors
93.29% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---